Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

NCT06983899
Recruiting
Exercise Training for the Improvement of Immune Activity and Treatment Outcomes During Immunotherapy for Non-small Cell Lung Cancer, BOOST Trial
Not applicable · United States · 1 site
Registry update: 23 Jun 2026
NCT07439887
Recruiting
Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease
Phase 1/2 · United States · 3 sites
Registry update: 15 Apr 2026
NCT07463196
Recruiting
A Study Investigating the Safety, Absorption, Elimination, and the Effect on the Immune System of ACI-19764 in Healthy Participants and in Participants With Cardiovascular Risk Factors
Phase 1 · Netherlands · 1 site
Registry update: 2 Sept 2026
NCT07388394
Recruiting
Polypharmacy on Healthy Aging in People Living With HIV Over the Age of 75
Not applicable · France · 1 site
Registry update: 29 Oct 2026
NCT07064291
Recruiting
Enhancing Self-Esteem in Patients With Multiple Sclerosis: A Randomised Controlled Trial of the Lexical Association Technique
Not applicable · France · 1 site
Registry update: 2 Oct 2026
NCT07323654
Recruiting
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Phase 2 · Argentina, Austria, Belgium, Germany, Spain, United Kingdom, Italy, South Korea, Poland, Romania, Serbia, Slovakia, United States · 77 sites
Registry update: 6 Oct 2026
NCT07385001
Recruiting
A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC
Phase 1/2 · China · 1 site
Registry update: 3 Feb 2026
NCT06639191
Recruiting
[177Lu]Lu-AKIR001 First-in-human Study
Early phase 1 · Sweden · 1 site
Registry update: 30 Jan 2026
NCT07363642
Recruiting
Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab
Phase 3 · China · 44 sites
Registry update: 4 Nov 2026
NCT07432360
Recruiting
Detecting Clinically Significant Prostate Cancer With Advanced MRI Protocols and Extensive Histopathology
Not applicable · Brazil · 1 site
Registry update: 25 Feb 2026
NCT07380711
Recruiting
Long-term Real-world Study of Dupilumab in COPD : Patient Characteristics, Safety and Patient-reported Outcomes
Not applicable · France · 28 sites
Registry update: 21 Sept 2026
NCT07256236
Recruiting
SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer
Phase 2 · China · 14 sites
Registry update: 30 Mar 2026
NCT07613385
Recruiting
Individualized AML Treatment
Not applicable · United States · 1 site
Registry update: 6 Oct 2026
NCT07440511
Recruiting
Spleen Stiffness Measurement for the Detection of Advanced Fibrosis
Not applicable · Italy · 1 site
Registry update: 27 Feb 2026
NCT07438106
Recruiting
A Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as Conversion Therapy for Locally Advanced Pancreatic Cancer
Phase 2 · China · 1 site
Registry update: 12 Aug 2026
NCT07278557
Recruiting
Sparing Parotid Ducts Via MRI Sialography for Reduced Patient-Reported Xerostomia
Phase 2 · United States · 1 site
Registry update: 13 Oct 2026
NCT06909045
Recruiting
Adaptive vs. Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
Not applicable · Belgium, Netherlands · 4 sites
Registry update: 29 Jan 2026
NCT07359599
Recruiting
The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension
Phase 4 · Belgium · 7 sites
Registry update: 30 Jan 2026
NCT07281976
Recruiting
A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer
Phase 1/2 · China · 7 sites
Registry update: 12 Feb 2026
NCT07172958
Recruiting
Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)
Phase 1 · United States · 2 sites
Registry update: 13 Aug 2026

Ordered by registry start date. Freshness and sponsorship never change the order.